Absolutely it is about 200x more risky for the shorts as it was in June. 2 DSMC reviews passed with flying colors, no changes to phase 3 trial, only covid trial to finish with mortality as primary endpoint. EIND’s reinstated while we wait for EUA. I don’t see path in which CYDY doesn’t get at the very min an EUA with 2+Billion revenue very soon, if pvalue as good as many think it should get full approval. Unblinding the data should be very quick and DSMC should have 75% data already to provide fda on 28th day so immediate EUA based on that already complied data is a very real possibility. I also think phillipines has very good shot at locking in an EUA as soon as president gets budget approval on Dec 28th. We may see a PR before that. So many near term catalyst that we also should see out first patients in long haulers trail which should fill rapidly with a waiting list and see some great media coverage. I will not be selling a single share until we hit $25-$35 and will only be small percentage. Way to much going for this company and to many worried about shorts. If illegal shorting/shorting wasn’t a thing you would see this stock rise everyday for past month and really rise like crazy the next 2 weeks in anticipation of great phase 3 trial results.